Literature DB >> 6137621

Concentrated aerosol formulations in asthma.

J H Toogood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6137621     DOI： 10.1016/s0140-6736(83)92318-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  The place of high-dose inhaled corticosteroids in asthma therapy.

Authors:  M J Smith
Journal:  Drugs       Date:  1987-05       Impact factor: 9.546

Review 2.  Therapeutic aerosols 2--Drugs available by the inhaled route.

Authors:  S W Clarke; S P Newman
Journal:  Thorax       Date:  1984-01       Impact factor: 9.139

Review 3.  Once-daily inhaled corticosteroids in children with asthma: dry powder inhalers.

Authors:  C Möller
Journal:  Drugs       Date:  1999       Impact factor: 9.546

Review 4.  Beclomethasone dipropionate. A reappraisal of its pharmacodynamic properties and therapeutic efficacy after a decade of use in asthma and rhinitis.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-08       Impact factor: 9.546

5.  Twice daily beclomethasone dipropionate administered with a concentrated aerosol inhaler: efficacy and patient compliance.

Authors:  M J Smith; M E Hodson
Journal:  Thorax       Date:  1986-12       Impact factor: 9.139

Review 6.  Budesonide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in asthma and rhinitis.

Authors:  S P Clissold; R C Heel
Journal:  Drugs       Date:  1984-12       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.